TFS Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-14,851
Closed -$869K 412
2017
Q2
$869K Buy
+14,851
New +$772K 0.34% 84
2017
Q1
Sell
-36,235
Closed -$1.91M 896
2016
Q4
$1.91M Sell
36,235
-8,193
-18% -$397K 0.51% 4
2016
Q3
$1.98M Sell
44,428
-1,206
-3% -$52.3K 0.47% 11
2016
Q2
$1.74M Sell
45,634
-6,715
-13% -$295K 0.32% 40
2016
Q1
$2.16M Sell
52,349
-33,215
-39% -$1.37M 0.31% 43
2015
Q4
$4.15M Sell
85,564
-69,174
-45% -$3.08M 0.45% 44
2015
Q3
$6.19M Buy
154,738
+114,293
+283% +$4.99M 0.6% 10
2015
Q2
$1.62M Buy
+40,445
New +$1.4M 0.16% 202

Other funds holding SYNH

TFS Capital's SYNH Position: Q3 2017 in Review

TFS Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2017, closing a stake of 14,851 shares — an estimated $869K sold.

TFS Capital first reported a position in SYNH in Q2 2015 and held it in 8 quarters. The position peaked at $6.19M in Q3 2015. 238 funds tracked by Wall St. Rank hold SYNH as of Q3 2017.

  • TFS Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 14,851 Syneos Health, Inc. Class A Common Stock shares in Q3 2017, an estimated $869K.
  • TFS Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 8 quarters.
  • TFS Capital's Syneos Health, Inc. Class A Common Stock position peaked at $6.19M in Q3 2015.
  • 238 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.